Search research articles
Contact Us
Filters
Showing results (401-410 of 412) with videos related to
Page
of 42
Sort By:
Frontiers in Neurology
|
June 28, 2021
Reproducibility and Characterization of Head Kinematics During a Large Animal Acceleration Model of Traumatic Brain Injury
Andrew R Mayer, Josef M Ling, Andrew B Dodd, et al.
Neurology
|
April 3, 2015
Loss of PCLO function underlies pontocerebellar hypoplasia type III
Mustafa Y Ahmed, Barry A Chioza, Anna Rajab, et al.
Human Mutation
|
August 6, 2016
Novel Genetic, Clinical, and Pathomechanistic Insights into TFG-Associated Hereditary Spastic Paraplegia
Gaurav V Harlalka, Meriel E McEntagart, Neerja Gupta, et al.
BMJ Open Sport & Exercise Medicine
|
March 24, 2025
Distribution of position-specific head impact severities among professional and Division I collegiate American football athletes during games
Lee F Gabler, Declan A Patton, Kristen A Reynier, et al.
The Journal of Clinical Investigation
|
June 10, 2014
Hypomorphic PCNA mutation underlies a human DNA repair disorder
Emma L Baple, Helen Chambers, Harold E Cross, et al.
Plos Genetics
|
January 13, 2017
Mutations in HYAL2, Encoding Hyaluronidase 2, Cause a Syndrome of Orofacial Clefting and Cor Triatriatum Sinister in Humans and Mice
Martina M A Muggenthaler, Biswajit Chowdhury, S Naimul Hasan, et al.
Genome Research
|
June 5, 2019
Growth disrupting mutations in epigenetic regulatory molecules are associated with abnormalities of epigenetic aging
Aaron R Jeffries, Reza Maroofian, Claire G Salter, et al.
Brain : a Journal of Neurology
|
January 6, 2017
A mutation of EPT1 (SELENOI) underlies a new disorder of Kennedy pathway phospholipid biosynthesis
Mustafa Y Ahmed, Aisha Al-Khayat, Fathiya Al-Murshedi, et al.
The Journal of Clinical Investigation
|
April 2, 2013
SLITRK6 mutations cause myopia and deafness in humans and mice
Mustafa Tekin, Barry A Chioza, Yoshifumi Matsumoto, et al.
Cancer Investigation
|
July 29, 1998
A comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppression
R A Beveridge, J A Miller, A N Kales, et al.
Page
of 42
Search research articles
Search
Showing results (401-410 of 412) with videos related to
Sort By:
Page
of 42
Frontiers in Neurology
|
June 28, 2021
Reproducibility and Characterization of Head Kinematics During a Large Animal Acceleration Model of Traumatic Brain Injury
Andrew R Mayer, Josef M Ling, Andrew B Dodd, et al.
Neurology
|
April 3, 2015
Loss of PCLO function underlies pontocerebellar hypoplasia type III
Mustafa Y Ahmed, Barry A Chioza, Anna Rajab, et al.
Human Mutation
|
August 6, 2016
Novel Genetic, Clinical, and Pathomechanistic Insights into TFG-Associated Hereditary Spastic Paraplegia
Gaurav V Harlalka, Meriel E McEntagart, Neerja Gupta, et al.
BMJ Open Sport & Exercise Medicine
|
March 24, 2025
Distribution of position-specific head impact severities among professional and Division I collegiate American football athletes during games
Lee F Gabler, Declan A Patton, Kristen A Reynier, et al.
The Journal of Clinical Investigation
|
June 10, 2014
Hypomorphic PCNA mutation underlies a human DNA repair disorder
Emma L Baple, Helen Chambers, Harold E Cross, et al.
Plos Genetics
|
January 13, 2017
Mutations in HYAL2, Encoding Hyaluronidase 2, Cause a Syndrome of Orofacial Clefting and Cor Triatriatum Sinister in Humans and Mice
Martina M A Muggenthaler, Biswajit Chowdhury, S Naimul Hasan, et al.
Genome Research
|
June 5, 2019
Growth disrupting mutations in epigenetic regulatory molecules are associated with abnormalities of epigenetic aging
Aaron R Jeffries, Reza Maroofian, Claire G Salter, et al.
Brain : a Journal of Neurology
|
January 6, 2017
A mutation of EPT1 (SELENOI) underlies a new disorder of Kennedy pathway phospholipid biosynthesis
Mustafa Y Ahmed, Aisha Al-Khayat, Fathiya Al-Murshedi, et al.
The Journal of Clinical Investigation
|
April 2, 2013
SLITRK6 mutations cause myopia and deafness in humans and mice
Mustafa Tekin, Barry A Chioza, Yoshifumi Matsumoto, et al.
Cancer Investigation
|
July 29, 1998
A comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppression
R A Beveridge, J A Miller, A N Kales, et al.
Page
of 42